Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility

Nat Struct Mol Biol. 2007 Mar;14(3):215-23. doi: 10.1038/nsmb1208. Epub 2007 Feb 18.

Abstract

Many features of the cancer cell phenotype emerge as a result of cooperation between multiple oncogenic mutations. Here we show that activated Ras(V12) and loss of p53 function can cooperate to promote cell motility, a feature closely associated with cancer progression to malignancy. Our analysis indicates that Ras(V12) and loss of p53 synergistically induce RhoA activity, revealing a previously unknown role for p53 in tumor suppression. p53 prevents activation of RhoA and thus induction of cell motility by Ras(V12) through a simple signaling circuit, which integrates multiple inputs that converge on RhoA. Our data suggest that p53 suppresses cancer progression to malignancy by modulating the quality of Ras signaling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Movement*
  • Colon / cytology
  • Colon / pathology
  • Down-Regulation / genetics
  • Enzyme Activation
  • GTPase-Activating Proteins / metabolism
  • Humans
  • Mice
  • Models, Biological
  • Mutant Proteins / metabolism
  • Neoplasms / metabolism*
  • Neoplasms / pathology*
  • Phosphotyrosine / metabolism
  • Protein Transport
  • Tumor Suppressor Protein p53 / deficiency
  • Tumor Suppressor Protein p53 / metabolism*
  • Up-Regulation / genetics
  • ras Proteins / metabolism*
  • rhoA GTP-Binding Protein / genetics
  • rhoA GTP-Binding Protein / metabolism*

Substances

  • Arhgap5 protein, mouse
  • GTPase-Activating Proteins
  • Mutant Proteins
  • Tumor Suppressor Protein p53
  • Phosphotyrosine
  • ras Proteins
  • rhoA GTP-Binding Protein